AbCellera is not a COVID-19 company, CEO insists, even as Canadian developer reaps windfall from pandemic treatments - The Globe and Mail
![Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada](https://assets.ey.com/content/dam/ey-sites/ey-com/en_ca/people/V/ey-victoria-mcqueen-meta.jpg)
Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada
![How EY Entrepreneur Of The Year 2021 winner AbCellera is building a biotech powerhouse - The Globe and Mail How EY Entrepreneur Of The Year 2021 winner AbCellera is building a biotech powerhouse - The Globe and Mail](https://cloudfront-us-east-1.images.arcpublishing.com/tgam/GRJK2VACKJESPG7JHJQ6MVNY5I.jpg)
How EY Entrepreneur Of The Year 2021 winner AbCellera is building a biotech powerhouse - The Globe and Mail
![Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada](https://assets.ey.com/content/dam/ey-sites/ey-com/en_ca/news/2021/11/ey-eoy-banner-newsroom-enlgish.jpg)
Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada
![Ex-UBC prof Carl Hansen now worth more than $4 billion following spectacular AbCellera Biologics IPO | Georgia Straight Vancouver's News & Entertainment Weekly Ex-UBC prof Carl Hansen now worth more than $4 billion following spectacular AbCellera Biologics IPO | Georgia Straight Vancouver's News & Entertainment Weekly](https://www.straight.com/files/v3/styles/gs_feature/public/images/20/12/carl_hansen_2.jpg?itok=nB3fj4SL)
Ex-UBC prof Carl Hansen now worth more than $4 billion following spectacular AbCellera Biologics IPO | Georgia Straight Vancouver's News & Entertainment Weekly
![Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail](https://cloudfront-us-east-1.images.arcpublishing.com/tgam/F7F6TZHNOZHEDG26GLCL343RUM.jpg)